Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2005

01-01-2005 | Concise Article

High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil

Authors: C. A. Blal, S. R. L. Passos, C. Horn, I. Georg, M. G. Bonecini-Almeida, V. C. Rolla, L. De Castro

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2005

Login to get access

Abstract

To determine the prevalence and exposure factors associated with hepatitis B infection in tuberculosis patients with and without HIV type 1 coinfection, the presence of hepatitis B virus serological markers was investigated in a retrospective study. The seroprevalence of hepatitis B virus in patients with tuberculosis only was 14.6%, and in tuberculosis patients coinfected with HIV it increased to 35.8%. In patients with HIV and tuberculosis coinfection, homosexuality constituted the principal exposure factor, while in tuberculosis patients without HIV, a gradual increase in hepatitis B virus seroprevalence was noted along with increasing age. The results demonstrate that hepatitis B infection is highly prevalent in tuberculosis patients in Brazil and suggest that a vaccination program for the general population should be considered in order to prevent further hepatitis B infections.
Literature
1.
go back to reference Madrey WC (2000) Hepatitis B—an important public health issue. J Med Virol 61:362–366CrossRef Madrey WC (2000) Hepatitis B—an important public health issue. J Med Virol 61:362–366CrossRef
2.
go back to reference Puoti M, Airoldi M, Bruno R, Zanini B, Spinetti A, Pezzoli C, Patron A, Castelli F, Sacchi P, Fillice G, Carosi G (2002) Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev 4:27–35 Puoti M, Airoldi M, Bruno R, Zanini B, Spinetti A, Pezzoli C, Patron A, Castelli F, Sacchi P, Fillice G, Carosi G (2002) Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev 4:27–35
3.
go back to reference Brinker M, Ferdinand WN, Pauline ME, Dillen W, Juriaans S, Well J, Leeuwen R, Pakker N, Reiss P, Danner S, Weverling G, Lang J (2000) Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. AIDS 14:2895–2902CrossRef Brinker M, Ferdinand WN, Pauline ME, Dillen W, Juriaans S, Well J, Leeuwen R, Pakker N, Reiss P, Danner S, Weverling G, Lang J (2000) Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. AIDS 14:2895–2902CrossRef
4.
go back to reference Patel PA, Voigt MD (2002) Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States. Am J Gastroenterol 97:1198–1203CrossRef Patel PA, Voigt MD (2002) Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States. Am J Gastroenterol 97:1198–1203CrossRef
5.
go back to reference Aceti A, Pasquazzi C, Zechini B, Bac C (2002) Hepatotoxicity development during retroviral therapy containing protease inhibitors in patients with HIV. J AIDS 29:41–48 Aceti A, Pasquazzi C, Zechini B, Bac C (2002) Hepatotoxicity development during retroviral therapy containing protease inhibitors in patients with HIV. J AIDS 29:41–48
6.
go back to reference Wong WN, Wu PC, Yuen MF, Cheng CC, Yew WW, Wong PC, Tam CM, Leung CC, Lai CL (2000) Antituberculosis drug-related liver disfunction in chronic hepatitis B infection. Hepatology 31:201–206CrossRef Wong WN, Wu PC, Yuen MF, Cheng CC, Yew WW, Wong PC, Tam CM, Leung CC, Lai CL (2000) Antituberculosis drug-related liver disfunction in chronic hepatitis B infection. Hepatology 31:201–206CrossRef
7.
go back to reference Santos EA, Yoshida FT, Rolla VC, Mendes JM, Vieira IF, Arabe J, Gomes SA (2003) Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 22:92–98 Santos EA, Yoshida FT, Rolla VC, Mendes JM, Vieira IF, Arabe J, Gomes SA (2003) Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 22:92–98
8.
go back to reference Piroth L, Binquet C, Vergne M, Minello A, Livry C, Bour JB, Buisson M, Duong M, Grappin M, Portier H, Chavanet P (2002) The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 36:681–686CrossRef Piroth L, Binquet C, Vergne M, Minello A, Livry C, Bour JB, Buisson M, Duong M, Grappin M, Portier H, Chavanet P (2002) The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 36:681–686CrossRef
9.
go back to reference Tanaka J (2000) Hepatitis B epidemiology in Latin America. Vaccine 18:17–19CrossRef Tanaka J (2000) Hepatitis B epidemiology in Latin America. Vaccine 18:17–19CrossRef
10.
go back to reference Martelli CMT, Turchi MD, Souto FJD, Saez-Alquezar A, Andrade ALS, Zicker F (1999) Anti-HBc testing for blood donations in areas with intermediate hepatitis B endemicity. Rev Panam Salud Publica 6:69–73 Martelli CMT, Turchi MD, Souto FJD, Saez-Alquezar A, Andrade ALS, Zicker F (1999) Anti-HBc testing for blood donations in areas with intermediate hepatitis B endemicity. Rev Panam Salud Publica 6:69–73
11.
go back to reference Damme PV, Cramm M, Auwera JC, Vranckx R, Meheus A (1995) Horizontal transmission of hepatitis B virus. Lancet 345:27–29CrossRef Damme PV, Cramm M, Auwera JC, Vranckx R, Meheus A (1995) Horizontal transmission of hepatitis B virus. Lancet 345:27–29CrossRef
12.
go back to reference Fisher N, Georgsen J, Stolborg T, Khalil MR, Christensen PB (2002) Low hepatitis B prevalence among pre-school children in Denmark: saliva anti-HBc screening in day care centers. J Med Virol 68:500–504CrossRef Fisher N, Georgsen J, Stolborg T, Khalil MR, Christensen PB (2002) Low hepatitis B prevalence among pre-school children in Denmark: saliva anti-HBc screening in day care centers. J Med Virol 68:500–504CrossRef
13.
go back to reference Van der Eijk AA, Niesters HG, Gotz HM, Janssen HL, Schalm SW, Osterhaus AD, de Man RA (2004) Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent. J Clin Virol 29:92–94CrossRef Van der Eijk AA, Niesters HG, Gotz HM, Janssen HL, Schalm SW, Osterhaus AD, de Man RA (2004) Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent. J Clin Virol 29:92–94CrossRef
14.
go back to reference Cantwell MF, McKenna MT, McCray E, Onorato IM (1998) Tuberculosis and race/ethnicity in the United States. Am J Respir Crit Care Med 157:1016–1020 Cantwell MF, McKenna MT, McCray E, Onorato IM (1998) Tuberculosis and race/ethnicity in the United States. Am J Respir Crit Care Med 157:1016–1020
15.
go back to reference Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD (2002) Hepatotoxicity associated with nevirapine or efavirenz containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology 35:182–189CrossRef Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD (2002) Hepatotoxicity associated with nevirapine or efavirenz containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology 35:182–189CrossRef
Metadata
Title
High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil
Authors
C. A. Blal
S. R. L. Passos
C. Horn
I. Georg
M. G. Bonecini-Almeida
V. C. Rolla
L. De Castro
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2005
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-004-1272-8

Other articles of this Issue 1/2005

European Journal of Clinical Microbiology & Infectious Diseases 1/2005 Go to the issue

Announcements

Announcements

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.